Table 1.

Immunophenotypes and survival in acute lymphoblastic leukemia (ALL) in children (ages 1–18) versus adults (ages 18 and older).

Immunophenotypes and survival in acute lymphoblastic leukemia (ALL) in children (ages 1–18) versus adults (ages 18 and older).
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal